Skip to main content
SpringerLink
Log in

Superoxide dismutase modifications for anti-inflammatory therapy

  • Chapter
New Developments in Antirheumatic Therapy

Part of the book series: Inflammation and Drug Therapy Series ((IDTH,volume 3))

Abstract

In the early 1960s a metalloprotein with anti-inflammatory properties in man and animals was isolated from bovine liver1, which was, some years later identified as superoxide dismutase (SOD). This is a copper-zinc protein which has subsequently been purified and characterized by McCord and Fridovich2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Huber, W, Schulte, TL, Carson, S, Goldhammer, RE and Vogin, EE (1968). Some chemical and pharmacological properties of a novel anti-inflammatory protein. Toxicol Appl Pharmacol, 12, 308

    Google Scholar 

  2. McCord, JM and Fridovich, I (1969). Superoxide dismutase, an enzymatic function for erythrocuprein. J Biol Chem, 244, 6049–6055

    PubMed  CAS  Google Scholar 

  3. Huber, W, Nenander-Huber, KB, Saifer, MGP and Dang, PHC (1977). Studies on the clinical and laboratory pharmacology of drug formulations of bovine Cu-Zn superoxide dismutases (orgotein). In: Willoughby, DA, Giroud, JP and Velo GP (Eds), Perspectives in Inflammation, pp. 527–544. (Lancaster: MTP Press)

    Google Scholar 

  4. Edsmyr, F, Huber, W and Nenander-Huber, KB (1976). Orgotein efficacy in ameliorating side effects due to radiation therapy: I double-blind, placebo-controlled trial in patients with bladder tumors. Curr Ther Res, 19(2), 198–211

    PubMed  CAS  Google Scholar 

  5. Tetsuo, A, Makamoto, F, Yoshimasa, I, Kazuyuki, H, Mamoru, S and Katsuhito, S (1966). Effect of superoxide dismutase on glomerual nephritis. Biochem Pharmacol, 35(2), 341–345

    Article  Google Scholar 

  6. Huhn-Edholm, M, Ostling, E and Fellenius, E (1986). Superoxide dismutase enhances recovery following myocardial ischemia/reperfusion in vivo and in vitro. In: Rotilio, G (ed), Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine, pp. 591–593. (Amsterdam, New York, Oxford: Elsevier Science Publisher)

    Google Scholar 

  7. Lund-Olesen, K and Menander, KB (1974). Orgotein: A new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr Ther Res, 7, 706–717

    Google Scholar 

  8. Menander-Huber, KB and Huber, W (1980). Orgotein, the drug version of bovine Cu-Zn superoxide dismutase II. A summary account of clinical trials in man and animals. In: Michelson, AM, McCord, JM and Fridovich, I (eds), Superoxide and Superoxide Dismutase, pp. 537–549 (London, New York, San Francisco: Academic Press)

    Google Scholar 

  9. Goebel, KM and Storck, V (1983). Effect of intra-articular orgotein versus a corticosteroid on rheumatoid arthritis of the knee. Am J Med, 74, 124–128

    Article  PubMed  CAS  Google Scholar 

  10. Marberger, H, Huber, W, Bartsch, G, Schulte, T and Swoboda, P (1974). Orgotein: a new anti-inflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int Urol Nephrol, 6(2), 61–74

    Article  PubMed  CAS  Google Scholar 

  11. Wilsmann, KM (1986). Ten years of clinical experience with SOD treatment of inflammatory disorders. In: Rotilio, G (ed), Superoxide and Superoxide Dismutase in Chemistry, Biology and Medicine, pp. 500–505. (Amsterdam, New York, Oxford: Elsevier Science Publishers)

    Google Scholar 

  12. Greenwald, RA (1985). Therapeutic benefits of oxygen radical scavenger treatments remain unproven. J Free Rad Biol Med, 1, 173–177

    Article  CAS  Google Scholar 

  13. Giri, SN and Misra, HP (1984). Fate of superoxide dismutase in mice following oral route of administration. Med Biol, 62, 285–289

    PubMed  CAS  Google Scholar 

  14. Holcenberg, JS, Schmer, G, Teller, DC and Roberts, J (1975). Biologic and physical properties of succinilated and glycosylated Acinetobacter glutaminase-asparaginase. J Biol Chem, 250, 4165–4170

    PubMed  CAS  Google Scholar 

  15. Van den Berg, WB, Schalkwijk, J, Joosten, LAB and Van de Putte, LBA (1985). Experimental allergic arthritis in mice: effects of local enzyme therapy with native and cationic derivatives. Agents Actions, 17, 350–351

    Article  Google Scholar 

  16. Schalkwijk, J, Van den Berg, WB, Van de Putte, LBA, Joosten, LAB and Van den Bersselaar, LJ (1985). Cationization of catalase, peroxidase and superoxide dismutase. J Clin Invest, 76, 198–205

    Article  PubMed  CAS  Google Scholar 

  17. McCord, JM, Stokes, SH and Wong, K (1979). Superoxide radical as a phagocyte-produced chemical mediator of inflammation. In: Weissmann, G (ed), Advances in Inflammation Research, Vol. 1, pp. 273–280. (New York: Raven Press)

    Google Scholar 

  18. McCord, JM and Wong, K (1979). Phagocyte-produced free radicals: roles in cytotoxicity and inflammation. In: Oxygen Free Radicals and Tissue Damage, Ciba Foundation Symposium, Vol. 65, pp. 343–360. (Amsterdam, Oxford, New York: Excerpta Medica)

    Google Scholar 

  19. Topper, YJ, Oka, T, Vanderhaar, BK and Wilchek, M (1975). Characterization of super-active insulin, prolactin and placental lactogen. Biochim Biophis Res Comm, 66, 193–198

    Google Scholar 

  20. Broun, GB (1976). Chemically aggregated enzymes. Methods Enzymol, 44, 263–280

    Article  PubMed  CAS  Google Scholar 

  21. Quiocho, FA (1976). Immobilized proteins in single crystals. Methods Enzymol, 44, 546–558

    Article  PubMed  CAS  Google Scholar 

  22. Wong, K, Cleland, LG and Poznanski, MJ (1980). Enhanced anti-inflammatory effects and reduced immunogenicity of bovine liver superoxide dismutase by conjugation with homologous albumin. Agents Actions, 10, 231–239

    Article  PubMed  CAS  Google Scholar 

  23. Topchieva, IN (1980). Biochemical applications of pory(ethylenegrycol). Russian Chem Rev, 43, 260–271

    Article  Google Scholar 

  24. Ahe, A and Mark, JE (1980). Conformational energies and the random coil dimension and dipole moments of the polyoxides. J Am Chem Soc, 98, 6468–6476

    Google Scholar 

  25. Nogooka, S, Mori, Y, Takiuchi, H, Yokota, K, Tanzawa, H and Nishiumi, S (1984). Interaction between blood component and hydrogel with poly(oxyethylene) chains. In: Sholoby, SW, Hoffman, AS, Ratner, BD and Horbett, TA (eds), Polymers as Biomaterials, pp. 361–374. (New York: Plenum Press)

    Google Scholar 

  26. Inada, YI, Takahoshi, K, Yoshimoto, T, Ajima, A, Matsushima, A and Saito, Y (1986). Application of polyethylene glycol-modified enzymes in biotechnological processes: organic solvent soluble enzymes. Trends Biotech, 7, 190–194

    Article  Google Scholar 

  27. Abuchowski, A, Van Es, T, Palczuk, NC and Davis, FF (1977). Alteration of immunological properties of bovin serum albumin by covalent attachment of polyethylene glycol. J Biol Chem, 252, 3578–3581

    PubMed  CAS  Google Scholar 

  28. Abuchowski, A, McCoy, JR, Palczuk, NC, Van Es, T and Davis, FF (1977). Effect of covalent attachment of polyethylene glycol on immunogenicity and circulation life of bovine liver catalase. J Biol Chem, 252, 3582–3586

    PubMed  CAS  Google Scholar 

  29. Boccù, E, Velo, GP and Veronese, FM (1982). Pharmacokinetic properties of polyethylene glycol derivatized superoxide dismutase. Pharmacol Res Commun, 14, 113–120

    Article  PubMed  Google Scholar 

  30. Pyatak, PS, Abuchowski, A and Davis, FF (1980). Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulating life and anti-inflammatory activity. Res Commun Chem Pathol Pharmacol, 29, 113–127

    PubMed  CAS  Google Scholar 

  31. Beauchamp, CD, Gonias, SL, Menapace, DP and Pizzo, S (1983). A new procedure for the synthesis of polyethylene glycol-protein adducts: effects on function, receptor recognition and clearance of superoxide dismutase, lactoferrin and β-2-macroglobulin. Anal Biochem, 131, 25–33

    Article  PubMed  CAS  Google Scholar 

  32. Veronese, FM, Largajolli, R, Boccù, E, Benassi, CA and Schiavon, O (1985). Surface modification of proteins; activation of monomethoxy-polyethylene glycol by phenilchloroformates and modification of ribonuclease and superoxide dismutase. Appl Biochem Biotechnol, 11, 141–152

    Article  PubMed  CAS  Google Scholar 

  33. Conforti, A, Marrella, M, Milanino, R, Moretti, U, Velo, GP, Largajolli, R, Veronese, FM, Boccù, E and Schiavon, O (1986). Anti-inflammatory properties of superoxide dismutase derivatives (SOD-PEG-3 and SOD-PEG-18) in carrageenan pleurisy. In: Rotilio, G (ed), Superoxide and Superoxide Dismutase in Chemistry Biology and Medicine, pp. 532–534. (Amsterdam, New York, Oxford: Elsevier Sciences Publishers).

    Google Scholar 

  34. Conforti, A, Franco, L, Milanino, R, Velo, GP, Boccù, E, Largajolli, R, Schiavon, O and Veronese, FM (1987). PEG superoxide dismutase derivatives: anti-inflammatory activity in carrageenan pleurisy in rats. Pharmacol Res Commun, 19, 187–194

    Article  Google Scholar 

  35. Veronese, FM, Boccù, E, Schiavon, O, Velo, GP, Conforti, A, Franco, L and Milanino, R (1983). Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters. J Pharm Pharmacol, 35, 757–758

    Article  PubMed  CAS  Google Scholar 

  36. Nucci, ML, Olejarczyk, J and Abuchowski, A (1986). Immunogenicity of polyethylene glycol-modified superoxide dismutase and catalase. J Free Rad Biol Med, 2, 321–325

    Article  CAS  Google Scholar 

  37. Greenwald, RA (1986). Treatment of inflammatory arthritis with oxygen radical scavengers. J Free Rad Biol Med, 2, 367–368

    Article  CAS  Google Scholar 

  38. Viau, AT, Abuchowski, A, Greenspan, S and Davis, FF (1986). Safety evaluation of free radical scavengers PEG-catalase and PEG-superoxide dismutase. J Free Rad Biol Med, 2, 283–288

    Article  CAS  Google Scholar 

  39. Turrens, JF, Crapo, JD and Freeman, BA (1984). Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest, 73, 87–95

    Article  PubMed  CAS  Google Scholar 

  40. Freeman, BA, Turrens, JF, Mirza, Z, Crapo, JD and Young, SL (1985). Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc, 44, 2591–2595

    PubMed  CAS  Google Scholar 

  41. Pradmanabhan, RV, Gudapaty, R, Liener, IE, Schwartz, BA and Hoidal, JR (1985). Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalse. Am Rev Respir Dis, 132, 164–167

    Google Scholar 

  42. Michelson, AM, Puget, K and Durosay, P (1985). La superoxyde dismutase et la pathologie des radicaux Ubres. CR Soc Biol, 179, 429–439

    CAS  Google Scholar 

  43. Somiya, K, Niwa, K, Shimoda, K, Fukami, S, Puget, K and Michelson, M (1986). Treatment with liposomal superoxide dismutase of patients with Kawasaki disease. In: Rotilio, G (ed), Superoxide and Superoxide Dismutase in Chemistry Biology and Medicine, pp. 513–516. (Amsterdam, New York, Oxford: Elsevier Science Publisher)

    Google Scholar 

  44. McDonald, RJ, Berger, EM, White, CW, White, JC, Freeman, PA and Resine, JE (1985). Effects of superoxide dismutase encapsulated in liposomes or conjugated with polyethylene glycol on neutrophil bactericidal activity in vitro and bacterial clearance in vivo. Am Rev Respir Dis, 13, 633–637

    Google Scholar 

  45. Thorner, MO, Reschke, J, Chitwood, J, Rogol, AD, Furlanetto, R, Rivier, J, Vale, W and Blizzard, RM (1985). Development of antibody to growth hormone-releasing factor. N Engl J Med, 312, 994

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Farmaceutiche, Centro di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CNR, Università di Padova, Padova, Italy

    F. M. Veronese

  2. Istituto di Farmacologia, Università di Verona, Verona, Italy

    A. Conforti & G. P. Velo

Authors
  1. F. M. Veronese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Conforti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. P. Velo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biomedical Sciences, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

    K. D. Rainsford

  2. Institute of Pharmacology, University of Verona, Italy

    G. P. Velo

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Veronese, F.M., Conforti, A., Velo, G.P. (1989). Superoxide dismutase modifications for anti-inflammatory therapy. In: Rainsford, K.D., Velo, G.P. (eds) New Developments in Antirheumatic Therapy. Inflammation and Drug Therapy Series, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1253-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1253-3_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7056-0

  • Online ISBN: 978-94-009-1253-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation